Medicare Coverage Database (MCD)

The draft LCDs are available on the CMS MCD website:

Draft LCDs

When there are draft Local Coverage Determinations (LCDs) that are in the comment period, this webpage will provide a summary of comments received and Noridian's response. This information will remain on this webpage for at least six months.

Status Indicators

D = Draft under development, not yet released for comment
C = Draft LCD released for comment
E = Formal comment period has ended; comments now being considered
F = Final new/revised LCD has been issued for notice
A = Active policy: notice period complete and the policy is in effect

Send Draft LCD Comments to:

Mail:
Noridian Medicare JF Part B
Attention: Draft LCD Comments
PO Box 6781
Fargo, ND 58108-6781
Email: policydraft@noridian.com

X
 
LCD Title Release Date of Draft LCD for Comment End Date for Comment Period Current Status Comments/ Responses Received Date of Release for Notice Link to Final LCD
4Kscore Assay 02/08/17 04/10/17 E      
Chest X-Ray Policy 10/05/17 12/12/17 F View 03/19/18 View
Chiropractic Services 06/01/17 08/14/17 E      
Frequency of Hemodialysis 10/05/17 12/15/17 E      
Helicobacter Pylori Infection Testing 02/01/18 04/13/18 E      
In Vitro Chemosensitivity & Chemoresistance Assays 02/01/18 04/13/18 F View 08/23/18 View
Intraoperative Neurophysiological Testing 06/02/16 08/08/16 E      
Lumbar MRI 06/01/17 08/14/17 A View 7/12/18 View
Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor 06/07/18 08/14/18 E      
Micro-Invasive Glaucoma Surgery (MIGS) 02/01/18 04/13/18 E      
MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test 10/04/18 12/14/18 C      
MolDX: Corus® CAD Assay 02/01/18 04/13/18 E      
MolDX: Cystatin C Measurement 02/01/18 04/13/18 E      
MolDX: Decipher® Biopsy Prostate Cancer Classifier Assay for Men with Very Low and Low Risk Disease 10/04/18 12/14/18 C      
MolDX: DecisionDx-Melanoma 06/07/18 08/14/18 E      
MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test 10/04/18 12/14/18 C      
MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification Tests (NAATs) 06/01/17 8/14/17 E      
MolDX: Genetic Testing for Lynch Syndrome 10/04/18 12/14/18 C      
MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC) 02/01/18 04/13/18 F View 09/04/18 View
MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer 10/04/18 12/14/18 C      
MolDX: MDS FISH 02/01/18 04/13/18 E      
MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels 06/01/17 08/14/17 E      
MolDX: myPath Melanoma Assay 10/04/18 12/14/18 C      
MolDX: NeuroIDgenetix® Test for Depression 10/04/18 12/14/18 C      
MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC) 06/07/18 08/14/18 E      
MolDX: OncotypeDX® Genomic Prostate Score for Men with Favorable Intermediate Risk Prostate Cancer 06/01/17 08/14/17 F View [PDF] 01/31/18 View
MolDX: Pigmented Lesion Assay (PLA) 06/07/18 08/14/18 E      
MRI and CT Scans of the Head and Neck 06/01/17 08/14/17 F View 08/23/18 View
Noninvasive Extracranial Arterial Studies 06/01/17 08/14/17 E      
Noninvasive Peripheral Venous Studies 06/01/17 08/14/17 E      
Noninvasive Physiologic Studies of Upper and Lower Extremity Arteries 06/01/17 08/14/17 E      
Peripheral Nerve Stimulation 06/01/17 08/14/17 F View 09/17/18 View
Repetitive Transcranial Magnetic Stimulation (rTMS) in Adults with Treatment Resistant Major Depressive Disorder 02/08/17 04/10/17 F View 03/29/18 View
Respiratory Care (Respiratory Therapy) 06/01/17 08/14/17 F View 05/22/18 View
Visual Electrophysiology Testing 02/08/17 04/10/17 E      

 

When a "Draft" LCD becomes "Final/Future," go to the Future LCDs page to view a specific future LCD.

  • View All Future LCDs by state. Within the table, each state selection will redirect you to the MCD on the CMS website. Note: All LCDs for JE states are the same.

 

Last Updated Oct 08, 2018